25.40
Zymeworks Inc. Aktie (ZYME) Neueste Nachrichten
ZYME SEC FilingsZymeworks 10-K, 10-Q, 8-K Forms - Stock Titan
Zymeworks Inc. (ZYME) - Minichart
Zymeworks: Royalty-Backed Biotech Flywheel With Underappreciated ADC Optionality (ZYME) - Seeking Alpha
ZYME Technical Analysis | Trend, Signals & Chart Patterns | ZYMEWORKS INC (NASDAQ:ZYME) - ChartMill
Zymeworks authorizes fresh $125M share buyback - MSN
Zymeworks Inc stock (US98985W1080): buyback plan and insider equity awards draw fresh attention - AD HOC NEWS
Zymeworks grants RSUs and options to EVP | ZYME Insider Trading - Stock Titan
Zymeworks (ZYME) EVP files Form 3 reporting no share ownership - Stock Titan
Rubric Capital, David Rosen disclose 9.49% stake in Zymeworks (ZYME) - Stock Titan
Vanguard Group Inc. Increases Position in Zymeworks Inc. $ZYME - MarketBeat
Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock - The Manila Times
Zymeworks Authorizes 2026 Share Repurchase Program, Affirms Liquidity - TipRanks
Zymeworks authorizes $125 million share buyback program - Investing.com UK
Zymeworks authorizes $125 million share buyback program By Investing.com - Investing.com South Africa
Zymeworks Inc. announces an Equity Buyback for $125 million worth of its shares. - marketscreener.com
Zymeworks (NASDAQ: ZYME) launches $125M stock buyback and outlines runway - Stock Titan
Zymeworks Inc.'s Equity Buyback announced on November 16, 2025, has expired with 4,197,553 shares, representing 5.62% for $102.3 million. - marketscreener.com
Zymeworks to present at three major investor conferences in May and June 2026 - Pluang
Zymeworks Announces Participation in Upcoming Investor Conferences - Koreabizwire
About Us | Cabling Installation & MaintenanceZymeworks Announces Participation in Upcoming Investor Conferences - FinancialContent
Zymeworks Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:ZYME) 2026-05-12 - Seeking Alpha
Earnings call transcript: Zymeworks reports Q1 2026 revenue drop, outlines strategic advancements - Investing.com India
Earnings call transcript: Zymeworks reports Q1 2026 revenue drop, outlines strategic advancements By Investing.com - Investing.com Australia
Zymeworks Q1 2026 presentation: $250M milestone eyed amid revenue dip - Investing.com
Here's What Analysts Are Forecasting For Zymeworks Inc. (NASDAQ:ZYME) After Its First-Quarter Results - Yahoo Finance
Citizens reiterates Zymeworks stock rating on pipeline progress - Investing.com
How Wider Q1 Losses and FDA Priority Review for Zanidatamab At Zymeworks (ZYME) Has Changed Its Investment Story - simplywall.st
Zymeworks Q1 Earnings Call Highlights - TradingView
Number of shareholders of Zymeworks Inc. – NASDAQ:ZYME - TradingView
A Look At Zymeworks (ZYME) Valuation After Earnings Miss And Key FDA And Capital Return Updates - Yahoo Finance
Zymeworks Q1 2026 presentation: zanidatamab nears FDA decision By Investing.com - Investing.com South Africa
Zymeworks Down Over 9%, on Pace for Largest Percent Decrease Since December 2022 -- Data Talk - Moomoo
Zymeworks (NASDAQ:ZYME) Trading Down 8.9% After Earnings Miss - MarketBeat
Wells Fargo & Company Forecasts Strong Price Appreciation for Zymeworks (NASDAQ:ZYME) Stock - MarketBeat
Zymeworks Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Zymeworks Inc. (NASDAQ:ZYME) Q1 2026 Earnings Call Transcript - Insider Monkey
Zymeworks Inc. (ZYME) reports Q1 loss, misses revenue estimates - MSN
Zymeworks Inc. (ZYME) Stock Analysis: Exploring a 50% Upside Potential Amidst Strong Buy Ratings - DirectorsTalk Interviews
Zymeworks Q1 2026 presentation: zanidatamab nears FDA decision - Investing.com
Earnings call transcript: Zymeworks faces revenue decline in Q1 2026 By Investing.com - Investing.com Canada
Earnings call transcript: Zymeworks faces revenue decline in Q1 2026 - Investing.com
Zymeworks (ZYME) Q1 2026 Earnings Transcript - The Globe and Mail
Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Zymeworks Reports Q1 2026 Results and Pipeline Progress - TipRanks
Earnings Flash (ZYME) Zymeworks Inc. Reports Q1 Revenue $2.4M - marketscreener.com
Q1 2026 Zymeworks Inc Earnings Call Transcript - GuruFocus
Aug. 25 FDA decision could trigger $250M milestone for Zymeworks - Stock Titan
Zymeworks (NASDAQ: ZYME) monetizes Ziihera royalties and boosts cash above $400M - Stock Titan
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):